Clinical Trials
11 trialsNCT07378306 2026-04-21
FACT-TN
Sun Yat-sen University
Phase 2 Recruiting
NCT07457359 2026-03-09
NEOTRIO-2
Second Affiliated Hospital, School of Medicine, Zhejiang University
Phase 2 Recruiting
NCT07281976 2026-02-12
A Trial of LBL-024 Monotherapy or Combination Drug in Patients With Triple Negative Breast Cancer
Nanjing Leads Biolabs Co.,Ltd
Phase 1/2 Recruiting
NCT06682195 2026-01-14
Neoadjuvant Chemotherapy Combined With Toripalimab for TNBC (NEOTORCH-BREAST02)
First Affiliated Hospital of Zhejiang University
Phase 2 Recruiting
NCT07111832 2025-12-18
A Clinical Trial of SHR-A1811 in the Treatment of Triple-negative Breast Cancer
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Phase 3 Recruiting
NCT06735131 2025-12-03
The Optimal Radioimmunotherapy Combinations for Advanced TNBC
Sun Yat-sen University
Phase 2 Recruiting
NCT06371274 2025-08-12
A Study on the Efficacy and Safety of Oral All-trans Retinoic Acid Combined With Toripalimab in TNBC.
First Affiliated Hospital of Zhejiang University
Phase NA Recruiting
NCT06991790 2025-05-28
Sacituzumab Govitecan + Toripalimab as First - Line Therapy for Advanced Triple - Negative Breast Cancer and Biomarker Exploration
Peking University Cancer Hospital & Institute
Recruiting
NCT06878625 2025-03-25
A Multicenter, Prospective, Cohort Study of Trop-2 ADC Combination Therapy for Advanced Triple-negative Breast Cancer
Tianjin Medical University Cancer Institute and Hospital
Phase 2 Recruiting
NCT06387628 2024-08-02
LM-108 in Combination With PD-1 Based Treatment for Patients With Recurrent or Metastatic Triple - Negative Breast Cancer
Fudan University
Phase 2 Recruiting
NCT05955105 2024-05-21
A Study of ILB2109 and Toripalimab in Patients With Advanced Solid Malignancies
Innolake Biopharm
Phase 1/2 Recruiting